TY  - JOUR 
AU  - Szarek, Michael
AU  - Gil Extremera, Blas
PY  - 2019
UR  - http://hdl.handle.net/10481/58008
AB  - BACKGROUND The ODYSSEY OUTCOMES (Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome
During Treatment With Alirocumab) trial compared alirocumab with placebo, added to high-intensity or
maximum-tolerated statin treatment, after...
LA  - eng
PB  - Elsevier
TI  - Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events The ODYSSEY OUTCOMES Trial
DO  - 10.1016/j.jacc.2018.10.039
ER  -